EDSA
EDESA BIOTECH (EDSA)
NASDAQ
$6.88+$0.05 (+0.73%)
Price as of Jun 03, 2026 7:19 PM EDT
  • $64.2M
    Market Cap
  • 243.22%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
09/30/2025
09/30/2024
09/30/2023
09/30/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-3.7M
+27.30%
-2.9M
-39.89%
-4.8M
-64.05%
-13.3M
-25.70%
Depreciation and Amortization Expense
119,273
-35.89%
186,049
+1.41%
183,471
+55.24%
118,188
-0.51%
Total Operating Expenses
4.2M
+2.66%
4.1M
-6.67%
4.4M
-12.06%
5.0M
-12.19%
Operating Profit
-7.9M
+12.78%
-7.0M
-23.94%
-9.2M
-49.80%
-18.4M
-22.43%
Interest Income
2,558
-98.33%
153,498
-47.04%
289,846
+356.29%
63,523
+468.95%
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
2,558
-98.33%
153,498
-47.04%
289,846
+356.29%
63,523
+468.95%
Total Nonoperating Income and Expense
726,843
-14.03%
845,499
-0.43%
849,143
N/A
N/A
N/A
Income before Taxes
-7.2M
+16.46%
-6.2M
-26.33%
-8.4M
-52.28%
-17.5M
+31.52%
Income Taxes
800
0.00%
800
0.00%
800
0.00%
800
0.00%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-7.2M
+16.46%
-6.2M
-26.32%
-8.4M
-52.28%
-17.5M
+31.53%
Net Income from Continuing Operations Applicable to Common
-7.2M
+16.46%
-6.2M
-26.33%
-8.4M
-52.28%
-17.5M
+31.52%
Basic EPS and Net Income
-1.27
-34.20%
-1.93
N/A
N/A
N/A
N/A
N/A
Diluted EPS and Net Income
-1.27
-34.20%
-1.93
N/A
N/A
N/A
N/A
N/A
Basic Weighted Average Shares
5.7M
+77.54%
3.2M
+11.84%
2.9M
N/A
N/A
N/A
Diluted Weighted Average Shares
5.7M
+77.54%
3.2M
N/A
N/A
N/A
N/A
N/A
Balance Sheet
Cash and Cash Equivalents
10.8M
+940.39%
1.0M
-80.65%
5.4M
-24.39%
7.1M
-9.55%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
10.8M
+940.39%
1.0M
-80.65%
5.4M
-24.39%
7.1M
-9.55%
Total Current Assets
11.5M
+587.08%
1.7M
-73.97%
6.4M
-29.20%
9.1M
-24.80%
Accumulated Depreciation
N/A
N/A
52,548
+19.85%
43,846
+10.95%
39,518
+16.73%
Property and Plant and Equipment and Net
N/A
N/A
0
-100.00%
8,702
-31.45%
12,694
-15.31%
Total Long-Term Assets
N/A
N/A
0
-100.00%
8,702
-31.45%
12,694
-15.31%
Total Assets
13.5M
+254.76%
3.8M
-57.10%
8.9M
-23.20%
11.6M
-20.63%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
10.0M
N/A
N/A
N/A
Total Current Liabilities
1.1M
-41.15%
1.8M
+0.60%
1.8M
-14.90%
2.1M
+46.76%
Total Long-Term Debt
N/A
N/A
N/A
N/A
0
-100.00%
43,662
N/A
Total Long-Term Liabilities
N/A
N/A
0
-100.00%
19,773
N/A
0
-100.00%
Total Liabilities
1.1M
-41.15%
1.8M
-0.48%
1.8M
-15.69%
2.2M
+43.11%
Retained Earnings
-65.9M
+12.50%
-58.6M
+11.77%
-52.4M
+19.01%
-44.0M
+66.23%
Total Stockholders Equity
12.5M
+528.52%
2.0M
-71.89%
7.0M
-24.94%
9.4M
-28.08%
Total Shares Outstanding
7.1M
+119.92%
3.2M
+36.43%
2.4M
-85.71%
16.7M
+25.32%
Cash Flow
Cash from Operating Activities
-7.3M
+49.73%
-4.9M
-26.31%
-6.6M
-45.95%
-12.3M
-10.14%
Capital Expenditures
N/A
N/A
N/A
N/A
0
-100.00%
5,656
-7.97%
Cash from Investing Activities
N/A
N/A
N/A
N/A
0
+100.00%
-5,656
-7.97%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
17.0M
+2,776.69%
592,031
-87.74%
4.8M
-58.47%
11.6M
-17.96%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-82.86%
-14.70%
-97.13%
+18.69%
-81.84%
-39.00%
-134.16%
+27.44%
Return on Equity
-99.57%
-27.14%
-136.66%
+34.14%
-101.88%
-34.84%
-156.34%
+15.36%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
10.67
+1,067.63%
0.91
-74.12%
3.53
-16.81%
4.25
-48.76%
Cash Ratio
10.01
+1,667.90%
0.57
-80.77%
2.94
-11.16%
3.31
-38.37%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
1.42
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
1.12
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow